57 results
Page 2 of 3
8-K
EX-99.1
r4mqya65h3e7 3h8z7u
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-99.1
yjjg5tzk
13 May 24
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:15am
8-K
EX-99.1
lrodihcg
28 Mar 24
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:00am
8-K
EX-99.1
giup4wn igd
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
CORRESP
cn4j4
19 Dec 11
Correspondence with SEC
12:00am
424B5
t4bdly
15 Jun 23
Prospectus supplement for primary offering
4:54pm
8-K
5u80z3f1uv0w2
19 May 11
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-10.5
prd85ma
1 Mar 11
Departure of Directors or Certain Officers
12:00am